Results 91 to 100 of about 384,012 (260)

Hereditary Transthyretin Amyloid Cardiomyopathy [PDF]

JAMA Cardiology, 2022
Quentin R, Youmans, Sanjiv J, Shah, Sadiya S, Khan   +2 more
openaire   +2 more sources

Free‐Breathing, 3D Cardiac Magnetic Resonance Elastography for Myocardial Stiffness Mapping

Magnetic Resonance in Medicine, Volume 95, Issue 4, Page 2356-2369, April 2026.
ABSTRACT Purpose Magnetic resonance elastography (MRE) of the heart has predominantly utilized breath‐held acquisitions with limited anatomic coverage. This work investigates the feasibility of 3D, free‐breathing cardiac MRE. Methods A 3D hybrid radial and EPI acquisition is utilized and combined with retrospective binning of k‐space via physiologic ...
Nolan K. Meyer, Yi Sui, Jessica Magnuson, Phillip J. Rossman, Kevin J. Glaser, Matthew C. Murphy, Armando Manduca, Ian C. Chang, Kiaran P. McGee, Kejal Kantarci, Ekta Kapoor, Philip A. Araoz, Richard L. Ehman, Joshua D. Trzasko, Arvin Arani   +14 more
wiley   +1 more source

Recurrent Syncope, a Clue in Amyloid Cardiomyopathy

Case Reports in Medicine, 2018
Infiltrative cardiomyopathies include a variety of disorders that lead to myocardial thickening resulting in a constellation of clinical manifestations and eventually heart failure that could be the first clue to reach the diagnosis.
Julian A. Marin-Acevedo, Catalina Sanchez-Alvarez, Ali A. Alsaad, Ricardo J. Pagán   +3 more
doaj   +1 more source

Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis [PDF]

, 2016
Search strategy.
Lei Zhao, Quan Fang, Zhuang Tian
core   +2 more sources

Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review [PDF]

, 2020
Background A growing number of epidemiological studies indicate that metabolic syndrome (MetS) and its associated features play a key role in the development of certain degenerative brain disorders, including Alzheimer’s disease and vascular dementia ...
Bell, J.D., Bell, J.D., Bligh, S.W.A., Bligh, S.W.A., Katsuno, T., Katsuno, T., Parkinson, J., Parkinson, J., Shinjyo, N., Shinjyo, N.   +9 more
core   +1 more source

Inotersen therapy of transthyretin amyloid cardiomyopathy [PDF]

Amyloid, 2019
Background: Cardiomyopathy is a major cause of death in patients with systemic transthyretin amyloidosis. Long term effect of therapy designed to inhibit hepatic production of the amyloid precursor has not been established in cardiomyopathy. The purpose of this study was to evaluate the long term safety and efficacy of transthyretin specific antisense ...
Noel R, Dasgupta, Stacy M, Rissing, Jessica, Smith, Jeesun, Jung, Merrill D, Benson   +4 more
openaire   +2 more sources

The relationships between ethnoracial identity, Aβ positivity, APOEε4, and medial temporal lobe tau PET

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION Clarifying relationships between amyloid, tau, and cognition is crucial to understanding dementia risk, but has been mainly performed in non‐Hispanic White (NHW) participants. It is unknown whether findings are generalizable to other ethnoracial groups.
Koral V. Wheeler, Victoria R. Tennant, Noelle N. Lee, Maxwell W. Hand, Suchita Ganesan, Patrick Walsh, Meral Tubi, Jamie A. Terner, Brandon Hall, Marylan Davison, Arthur W. Toga, Sid O'Bryant, Alexandra L. Clark, Kristine Yaffe, Meredith N. Braskie, for the HABS‐HD Study Team, Meredith Braskie, Kevin King, James R Hall, Melissa Petersen, Raymond Palmer, Robert Barber, Yonggang Shi, Fan Zhang, Rajesh Nandy, Roderick McColl, David Mason, Bradley Christian, Nicole Phillips, Stephanie Large, Joe Lee, Badri Vardarajan, Monica Rivera Mindt, Amrita Cheema, Lisa Barnes, Mark Mapstone, Annie Cohen, Amy Kind, Ozioma Okonkwo, Raul Vintimilla, Zhengyang Zhou, Michael Donohue, Rema Raman, Matthew Borzage, Michelle Mielke, Beau Ances, Ganesh Babulal, Jorge Llibre-Guerra, Carl Hill, Rocky Vig   +49 more
wiley   +1 more source

High profile transvalvular microaxial flow pump as a bridge to heart transplantation for amyloid cardiomyopathy: A case series

JHLT Open
Background: The definitive treatment for end-stage heart failure (ESHF) due to amyloid cardiomyopathy (ACM) is an orthotopic heart transplant (OHT).
Pankaj Garg, MBBS, Mohammad Alomari, MD, Ishaq Wadiwala, MBBS, Melissa Lyle, MD, Si Pham, MD, Nafiye Busra Celik, MD, Juan C. Leoni Moreno, MD, Rohan Goswami, MD, Kevin Landolfo, MD, Jose Nativi-Nicolau, MD, Daniel Yip, MD, Parag C. Patel, MD, Basar Sareyyupoglu, MD   +12 more
doaj   +1 more source

Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis

ESC Heart Failure, 2023
Aims Wildtype transthyretin amyloid cardiomyopathy is an under‐recognized cause of heart failure in elderly patients. Transcatheter tricuspid valve repair is a newly emerging therapeutic option for severe tricuspid regurgitation (TR).
Isabel A. Hoerbrand, Martin J. Volz, Fabian Aus dem Siepen, Matthias Aurich, Philipp Schlegel, Nicolas A. Geis, Ute Hegenbart, Mathias H. Konstandin, Norbert Frey, Philip W. Raake   +9 more
doaj   +1 more source

Negative [99mTc]Tc ‐DPD Scintigraphy, Presence of Monoclonal Protein and Biopsy Suggestive of AL Amyloidosis in a Patient With Homozygous p.Ala101Val Transthyretin Gene Variant

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Amyloidosis is a rare disease associated with the deposition of misfolded proteins that damage multiple organs, leading to a wide range of symptoms. The most frequently implicated proteins in amyloidosis include immunoglobulin Free Light Chains (FLC), related to AL amyloidosis, and transthyretin (TTR), which is responsible for ATTR amyloidosis.
Paulina Kryszpin, Piotr Jachimowski, Łukasz Augustowski, Mateusz Ziarkiewicz, Grzegorz Basak, Marta Lipowska, Marta Legatowicz‐Koprowska, Bogna Ziarkiewicz‐Wróblewska, Monika Gawor‐Prokopczyk   +8 more
wiley   +1 more source